In addition, MYSM1 was negatively associated with the CRC stage (≤ IIIB or ≥ IIIC, P = 0.032) and the tumor stage (≤ T3 or T4, P = 0.026) (Table 1). This evidence concerns the gene MYSM1 and colorectal carcinoma.